Pharmacy news

• Intravenous Immunoglobulin In Solid-Organ Transplantation

  10-06-2026 19:29 via pharmacypracticenews.com
  Amy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaThe survival of kidney and lung allografts continues to be threatened by sensitization, donor-specific antibody (DSA) formation, and antibody-mediated rejection (AMR). Intravenous immunoglobulin (IVIG) has been incorporated into 3 major clinical contexts central to transplant medicine: des
  
  Read more

• PBM–Pharmacy Collaboration Improves Medicaid Outcomes

  10-06-2026 19:27 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawA pharmacy benefit manager (PBM)–community pharmacy collaboration focused on expanding access to care for Medicaid members with chronic conditions significantly improved patient outcomes, increasing medication adherence by 6 to 11 percentage points across almost all drug categories after program participation, according to a new report from the Elevance Health Public Policy Institute.Patients engaged in
  
  Read more

• Managing Tardive Dyskinesia: Drug-Induced Risks and Therapeutic Advances

  10-06-2026 19:27 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumKatherine Sarna, PharmD, BCPSUIC Retzky College of PharmacyDrug Information GroupChicago, IllinoisTardive dyskinesia (TD) is a chronic movement disorder that can appear after long-term treatment with dopamine receptor–blocking agents (DRBAs), especially antipsychotics used for conditions such as schizophrenia and bipolar disorder.1,2Common symptoms of TD include involuntary movements of the face, mouth, or tongue, i
  
  Read more

• Pharmacists Are Critical In Opioid Use Disorder Care

  10-06-2026 19:26 via pharmacypracticenews.com
  By Marcus A. BanksA recently signed bill that provides specialized opioid use disorder (OUD) training to pharmacists, coupled with several best-practice models for supporting these patients in a wide range of practice settings, has underscored the value the profession brings to this challenging condition.Whatever site of care is involved, taking a personalized approach is a key to success, according to Ashley Maister, PharmD, BCPP, a psychiatric clinical pharmacy practitioner at Corporal Michael
  
  Read more

• Advertisement

• A Call to Action: Dismantle the ‘Patient as Payor’ Model

  10-06-2026 18:22 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksConcern over out-of-pocket prescription costs remains for patients and pharmaceutical industry leaders alike, according to speakers at Asembia’s AXS25 Summit, in Las Vegas.“Insurance dynamics are getting more complex and restrictive, which means that out-of-pocket costs for patients are continuing to increase [annually],” said Divya Iyer, MBA, MS, the senior vice president of go-to-mark
  
  Read more

• Finding the Right Entry Point In a Shifting Home Infusion Market

  10-06-2026 18:00 via pharmacypracticenews.com
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina Shaw Justin WhitsettAs drug manufacturers increasingly redesign therapies to move across sites of care, from hospital outpatient departments to infusion centers to the home, pharmacy leaders can no longer assume that a single business model will sustain growth. Instead, success in today’s home infusion market depends on understanding where therapies sit in their life cycle, which sites of care best match pat
  
  Read more

• Acta Medical Expands Access to Cleanroom Supplies Via Premier Inc. Contract

  10-06-2026 12:04 via pharmacypracticenews.com
  Acta Medical LLC, a leader in cleanroom and pharmaceutical supplies, announced it has entered into a contract with Premier Inc., one of the nation’s largest Healthcare Group Purchasing Organizations. This agreement will provide Premier’s extensive network of member hospitals, clinics, and healthcare providers with streamlined access to Acta Medical’s comprehensive line of Cleanroom supplies, enhancing patient care and operational efficiency.Under the terms of the agreement, Act
  
  Read more

• Tecentriq Approved for Muscle-Invasive Bladder Cancer

  10-06-2026 11:50 via pharmacypracticenews.com
  Originally published by our sister publication Clinical Oncology NewsBy Jennifer KulpaThe FDA has approved atezolizumab (Tecentriq, Genentech) and atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech) as adjuvant treatments for muscle-invasive bladder cancer (MIBC) after cystectomy in adults with circulating tumor DNA molecular residual disease (ctDNA MRD) as determined by an FDA-authorized test.The agency also approved the Signatera CDx assay as a companion diagnostic to identify p
  
  Read more

• Advertisement

Follow @newsl_pharmacy on Twitter!